Skip to main content
. 2013 Aug 13;109(5):1147–1156. doi: 10.1038/bjc.2013.453

Table 4. Factors associated with non-compliance in the re-excision group (N=198).

   
 
Univariate analysis
Multivariate analysis
  Compliant decisions N=170,N (%) Non-compliant decisions N=28,N (%) P-value OR (95% CI) P-value
Age at diagnosis, years
 
 
0.4
 
 
⩽35 5 (71.4) 2 (28.6)      
35–80 153 (86.4) 24 (13.6)      
⩾80
12 (85.7)
2 (14.3)
 
 
 
Postmenauposal status
 
 
0.7
 
 
No 68 (87.2) 10 (12.8)      
Yes
100 (84.8)
18 (15.2)
 
 
 
Tumour size, mm
 
 
0.3
 
 
⩽20 131 (85.1) 23 (14.9)      
20–40 33 (91.7) 3 (8.3)      
⩾40
6 (75.0)
2 (25.0)
 
 
 
Multifocal tumour
 
 
0.1
 
 
No 113 (89.0) 14 (11.0)      
Yes
57 (80.3)
14 (19.7)
 
 
 
Microinvasive tumour
 
 
0.04
 
 
No 160 (87.4) 23 (12.6)   1  
Yes
10 (66.7)
5 (33.3)
 
5.2 (1.5–17.5)
0.008
Prior neoadjuvant treatment
 
 
0.1
 
 
No 160 (87.0) 24 (13.0)   1  
Yes
10 (71.4)
4 (28.6)
 
4.2 (1.1–15.1)
0.03
Frequent patient profile
 
 
0.1
 
 
No 106 (82.8) 22 (17.2)      
Yes
64 (91.4)
6 (8.6)
 
 
 
Surgical discovery of microinvasion
 
 
0.09
 
 
No 155 (87.6) 22 (12.4)   1  
Yes
15 (71.4)
6 (28.6)
 
4.2 (1.4–12.5)
0.01
Prior breast surgery
 
 
0.5
 
 
Lumpectomy 154 (86.5) 24 (13.5)      
Mastectomy
16 (80.0)
4 (20.0)
 
 
 
Recommended re-excision by mastectomy
 
 
0.8
 
 
No 93 (86.9) 14 (13.1)      
Yes 60 (84.5) 11 (15.5)      
Already done
17 (85.0)
3 (15.0)
 
 
 
<3 mm margins (in situ component)
 
 
1.0
 
 
No 111 (86.1) 18 (13.9)      
Yes
59 (85.5)
10 (14.5)
 
 
 
<3 mm margins (invasive component)
 
 
0.6
 
 
No 134 (86.4) 21 (13.6)      
Yes
36 (83.7)
7 (16.3)
 
 
 
Prior axillary surgery
 
 
0.6
 
 
Sentinel node procedure 112 (87.5) 16 (12.5)      
Axillary lymphadenectomy 30 (83.3) 6 (16.7)      
No axillary surgery
28 (82.4)
6 (17.6)
 
 
 
Sentinel node status
 
 
0.01
 
 
Negative 58 (80.6) 14 (19.4)      
Positive 54 (96.4) 2 (3.6)      
No sentinel node procedure 58 (82.9) 12 (17.1)      

Abbreviations: CI=confidence interval; OR=odds ratio.

Two missing data for postmenopausal status in compliant decisions. Fisher's exact test used for categorical variables in the univariate analysis. Variables with P<0.20 in the univariate analysis (multifocal tumour, microinvasive tumour, prior neoadjuvant treatment, frequent patient profile, surgical discovery of microinvasion, and sentinel node status) entered the multivariate analysis.